BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 29573419)

  • 1. Should surgery be part of the multimodality treatment for stage IIIB non-small cell lung cancer?
    Collaud S; Provost B; Besse B; Fabre D; Le Chevalier T; Mercier O; Mussot S; Fadel E
    J Surg Oncol; 2018 Jun; 117(7):1570-1574. PubMed ID: 29573419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Timing of Surgery after Neoadjuvant Chemoradiation in Locally Advanced Non-Small Cell Lung Cancer.
    Gao SJ; Corso CD; Wang EH; Blasberg JD; Detterbeck FC; Boffa DJ; Decker RH; Kim AW
    J Thorac Oncol; 2017 Feb; 12(2):314-322. PubMed ID: 27720827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing Survival of Patients With Marginally Operable Stage IIIA Non-Small-Cell Lung Cancer Receiving Chemoradiotherapy With or Without Surgery.
    Yang KL; Chang YC; Ko HL; Chi MS; Wang HE; Hsu PS; Lin CC; Yeh DY; Kao SJ; Jiang JS; Chi KH
    Clin Lung Cancer; 2016 Nov; 17(6):550-557. PubMed ID: 27378175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is lung cancer surgery justified in patients with direct mediastinal invasion?
    Doddoli C; Rollet G; Thomas P; Ghez O; Serée Y; Giudicelli R; Fuentes P
    Eur J Cardiothorac Surg; 2001 Aug; 20(2):339-43. PubMed ID: 11463554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role for Surgical Resection in the Multidisciplinary Treatment of Stage IIIB Non-Small Cell Lung Cancer.
    Bott MJ; Patel AP; Crabtree TD; Morgensztern D; Robinson CG; Colditz GA; Waqar S; Kreisel D; Krupnicka AS; Patterson GA; Broderick S; Meyers BF; Puri V
    Ann Thorac Surg; 2015 Jun; 99(6):1921-8. PubMed ID: 25912748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the fate of patients who undergo resections of very large, node-negative lung cancers using the National Cancer DataBase.
    Liu J; Hancock JG; Moreno AC; Wang Z; Boffa DJ; Detterbeck FC; Kim AW
    Eur J Cardiothorac Surg; 2016 Feb; 49(2):596-601. PubMed ID: 25890936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The predictive value of
    Mattoli MV; Massaccesi M; Castelluccia A; Scolozzi V; Mantini G; Calcagni ML
    Radiat Oncol; 2017 Jan; 12(1):4. PubMed ID: 28057034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. En bloc resection of non-small-cell lung cancer invading the spine.
    Schirren J; Dönges T; Melzer M; Schönmayr R; Eberlein M; Bölükbas S
    Eur J Cardiothorac Surg; 2011 Sep; 40(3):647-54. PubMed ID: 21334220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors in neoadjuvant treatment followed by surgery in stage IIIA-N2 non-small cell lung cancer: a multi-institutional study by the Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society).
    Couñago F; Montemuiño S; Martin M; Taboada B; Calvo-Crespo P; Samper-Ots MP; Alcántara P; Corona J; López-Guerra JL; Murcia-Mejía M; López-Mata M; Jové-Teixidó J; Chust M; Díaz-Díaz V; de Ingunza-Barón L; García-Cañibano T; Couselo ML; Del Cerro E; Moradiellos J; Amor S; Varela A; Puertas MM; Thuissard IJ; Sanz-Rosa D; de Dios NR
    Clin Transl Oncol; 2019 Jun; 21(6):735-744. PubMed ID: 30430394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Outcome of Surgical Treatment of Locally Advanced Lung Cancer after Induction Chemoradiotherapy].
    Tanahashi M; Yukiue H; Suzuki E; Yoshii N; Kitazawa S; Kaminuma Y; Niwa H
    Kyobu Geka; 2018 Apr; 71(4):278-283. PubMed ID: 29755101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved survival associated with neoadjuvant chemoradiation in patients with clinical stage IIIA(N2) non-small-cell lung cancer.
    Koshy M; Fedewa SA; Malik R; Ferguson MK; Vigneswaran WT; Feldman L; Howard A; Abdelhady K; Weichselbaum RR; Virgo KS
    J Thorac Oncol; 2013 Jul; 8(7):915-22. PubMed ID: 23608815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of trimodality therapy in patients with stage IIIA (N2-bulky) and stage IIIB non-small-cell lung cancer.
    Li J; Dai CH; Yu LC; Chen P; Li XQ; Shi SB; Wu JR
    Clin Lung Cancer; 2009 Sep; 10(5):353-9. PubMed ID: 19808194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome after en bloc resection of non-small-cell lung cancer invading the pulmonary sulcus and spine.
    Collaud S; Waddell TK; Yasufuku K; Pierre AF; Darling GE; Cypel M; Rampersaud YR; Lewis SJ; Shepherd FA; Leighl NB; Cho J; Bezjak A; Tsao MS; Keshavjee S; de Perrot M
    J Thorac Oncol; 2013 Dec; 8(12):1538-44. PubMed ID: 24389435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes and prognostic factors of non-small-cell lung cancer with lymph node involvement treated with induction treatment and surgical resection.
    Marulli G; Verderi E; Zuin A; Schiavon M; Battistella L; Perissinotto E; Romanello P; Favaretto AG; Pasello G; Rea F
    Interact Cardiovasc Thorac Surg; 2014 Aug; 19(2):256-62; discussion 262. PubMed ID: 24824495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant chemotherapy and radiotherapy followed by surgery in selected patients with stage IIIB non-small-cell lung cancer: a multicentre phase II trial.
    Stupp R; Mayer M; Kann R; Weder W; Zouhair A; Betticher DC; Roth AD; Stahel RA; Majno SB; Peters S; Jost L; Furrer M; Thierstein S; Schmid RA; Hsu-Schmitz SF; Mirimanoff RO; Ris HB; Pless M
    Lancet Oncol; 2009 Aug; 10(8):785-93. PubMed ID: 19604722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical Results of Non-small Cell Lung Cancer in Nepal.
    Thakur B; Yonghui D; Devkota M; Poudel B; Baral P
    JNMA J Nepal Med Assoc; 2014; 52(196):992-6. PubMed ID: 26982898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IIIB-T4 non-small cell lung cancer: indications and results of surgical treatment.
    Lucchi M; Viti A; Melfi F; Ambrogi M; Givigliano F; Dini P; Mussi A
    J Cardiovasc Surg (Torino); 2007 Jun; 48(3):369-74. PubMed ID: 17505443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant chemotherapy followed by surgery in lung cancer: Indian scenario.
    Kumar S; Saikia J; Kumar V; Malik PS; Madan K; Jain D; Bharati S
    Curr Probl Cancer; 2020 Jun; 44(3):100563. PubMed ID: 32265058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase III Study of Surgery Versus Definitive Concurrent Chemoradiotherapy Boost in Patients With Resectable Stage IIIA(N2) and Selected IIIB Non-Small-Cell Lung Cancer After Induction Chemotherapy and Concurrent Chemoradiotherapy (ESPATUE).
    Eberhardt WE; Pöttgen C; Gauler TC; Friedel G; Veit S; Heinrich V; Welter S; Budach W; Spengler W; Kimmich M; Fischer B; Schmidberger H; De Ruysscher D; Belka C; Cordes S; Hepp R; Lütke-Brintrup D; Lehmann N; Schuler M; Jöckel KH; Stamatis G; Stuschke M
    J Clin Oncol; 2015 Dec; 33(35):4194-201. PubMed ID: 26527789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of surgery versus chemoradiotherapy in patients with clinical or pathologic stage N3 non-small cell lung cancer.
    Raman V; Jawitz OK; Yang CJ; Voigt SL; Wang H; D'Amico TA; Harpole DH; Tong BC
    J Thorac Cardiovasc Surg; 2019 Dec; 158(6):1680-1692.e2. PubMed ID: 31606169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.